Advanced Western Blotting Solutions for SARS-CoV-2 Research and Serology Testing
Bio-Techne is committed to supporting our customers including scientists who are working to combat the COVID-19 pandemic. Our next-generation western blotting solutions can help accelerate COVID-19 research and serology testing by enabling rapid, highly sensitive and automated detection of proteins and serum antibodies involved in viral pathogenesis and host immune response.
Simple Western™ automated western blotting platforms offer minimal setup time, typical hands-free run times of 3 hours, and quantitative results that can be accessed remotely to minimize time in the lab while social distancing. Simple Western systems can be used in SARS-CoV-2 research and vaccine development to assess immune response, to characterize protein candidates for vaccine development and monitor their expression over time, and to quantitate vaccine manufacturing process intermediate contamination.
- Characterize the COVID-19 Immune Response with SARS-CoV-2 Serology Testing
- The SARS-CoV-2 Multi-Antigen Serology Module for Jess/Wes detects serum/plasma antibodies against N, S1 RBD, S1 full length, S2 full length and Spike (S1+ S2) viral antigens in a single run
- Simple Western SARS-CoV-2 IgG serology assay using whole viral lysates as capture antigens
- Research into SARS-CoV-2 Pathogenesis & Treatment
- Highly sensitive detection and quantitation of ACE2 and TMPRSS2
- Simple Westerns for SARS-CoV-2 Vaccine Development
- Serological assays to assess immune response to a vaccine
- Characterize vaccine proteins and monitor vaccine component expression over time
- Quantitate vaccine manufacturing process intermediate contamination
SARS-CoV-2 antigen-down serology test
Automated ACE2 binding assay
Simple Western systems are automated, hands-free western blotting platforms that can be used for antigen-down serology assays for SARS-CoV-2. Jess, can process 24 samples in 3 hours and offers the ability to use viral antigen ladders to measure serum antibodies reactive against multiple SARS-CoV-2 antigens simultaneously and provide information-rich views into differences in antibody binding patterns across patients. This approach also has promise as an orthogonal confirmatory test to validate results derived from lateral flow, ELISA or other immunoassay serology techniques.
Traditional Western blots are commonly used as a confirmation for antigen-down serological assays due to several technical advantages:
- Antibody binding to multiple viral antigens can be visualized simultaneously
- Antigen molecular weight information can be used to confirm specificity of antibody binding
However, traditional Western blots have many drawbacks in a fast-moving research or clinical setting including being slow, labor intensive and lacking reproducibility. Jess overcomes the drawbacks of traditional western blots by providing:
- Rapid time to results (3h to results)
- Automation and hands-free operation
- Quantitative results
- Multi-antigen binding profiles
- High specificity
How do SARS-CoV-2 Serological Assays on Simple Western work?
Serological assays on Simple Western load and separate a mixture of viral antigens according to their molecular weight. Simple Western is an open platform and users can utilize any antigens of relevance to their studies for serum antibody capture. Antigens can be recombinant viral proteins or viral lysates. After separation, viral antigens are immobilized using a proprietary immobilization chemistry. After immobilization, serum or plasma is introduced and IgG antibodies in the collected serum or plasma bind to the immobilized antigens. Anti-IgG, anti-IgM or other class- or isotype-specific secondary antibodies conjugated with HRP or a fluorescent tag can be used for detection.
Using a mixture of recombinant viral proteins or viral lysates in a serological assay may enable users to distinguish non-specific interactions and also provide rich insights into the relative binding capacity for several viral proteins in one run, providing increased confidence in results and a deeper understanding of the patient immune response.
Simple Western has a proven track record of being used for serology assays. In this application note, we demonstrate how Simple Western serology assays were used to measure the levels of autoantibodies against known lupus antigens in normal and lupus patient samples
Simple Western IgG SARS-CoV-2 serology assay using ladder of recombinant viral antigens as capture antigens
The SARS-CoV-2 Multi-Antigen Serology Module for Jess/Wes is an antigen down serology assay capable of detecting IgG serum antibodies reactive against 5 key viral antigens. Recombinant viral antigens are mixed and separated by size to create a ladder for capture of reactive serum antibodies. The module delivers the flexibility to utilize multiple viral antigens including the addition of proprietary vaccine antigens, providing more information about antibody binding profiles in each patient. Multiple patient samples can be processed in each 3-hour run, enabling scientists to characterize variability in the immune response to SARS-CoV-2.
The SARS-CoV-2 Multi-Antigen Serology Module provides all the antigens, controls, and diluents needed to develop your serological assay to detect serum antibodies reactive against recombinant Nucleocapsid protein (N), S1 Receptor Binding Domain protein (RBD), S1 subunit full length, S2 subunit full length, and Spike (S1+S2) viral antigens.
Simple Western SARS-CoV-2 IgG serology assay using whole viral lysates as capture antigens
Viral lysates can also be used as capture antigens to present the most biologically relevant epitopes for antibody capture. Further, viral lysates include all viral antigens which can provide rich views into multi-analyte antibody binding profiles in each run. This can be important in confirmatory testing and validation of other orthogonal SARS-CoV-2 serology tests.
Simple Westerns are not new to coronavirus research and can be used to measure host susceptibility and study how to block or reduce virus entry and virus replication. Check out a recent Nature Communications paper on how Simple Western was used to study the Middle Eastern Respiratory Syndrome (MERS) infection mechanism.
Simple Westerns are also being used to study the efficacy of novel COVID-19 therapeutics. In a recent Publication Spotlight, we describe an exciting new study just released in Research Square in which researchers at LSU and USC used Simple Westerns to detect and quantify ACE2 in lung cells in order to measure response to exposure to elovanoids ELV-N32 and ELV-N34.
Highly Sensitive Detection and Characterization of ACE2 and TMPRSS2
Simple Western assays allow for highly sensitive and quantitative measurement of Angiotensin-Converting Enzyme2 (ACE2) and TMPRSS2 in tissue and cell lysate samples. ACE2 is a receptor for SARS-CoV-2 that binds the S protein and acts as the entry receptor. Cellular serine protease TMPRSS2 cleaves the Spike receptor at S1/S2 and S2’ sites to enable S2 mediated cell fusion and infection. Some COVID-19 therapeutic approaches are targeting AC2 or TMPRSS2.
In this application note, off-the shelf antibodies from R&D Systems and Novus Biologicals were used in Simple Western ACE2 and TMPRSS2 assays that were highly sensitive over a large dynamic range, providing molecular weight information and even quantification of ACE2 and TMPRSS2 in human cells. This assay may be valuable in the development of ACE2- or TMPRSS-2-targeting therapies and to assess ACE2 density in various sample types as a measure for infection susceptibility. Read this application note to Learn More.
Simple Westerns are used routinely in vaccine development including in the following application areas:
- Serological assays to characterize immune response to a vaccine
- Characterizing vaccine proteins
- Monitoring vaccine component expression over time
- Quantitating vaccine manufacturing process intermediate contamination
Learn how scientists at DIOSynVax and The University of Cambridge, UK are using Simple Western in the Race to Develop a Vaccine for the COVID19 Coronavirus and quickly screen antibodies and DNA vaccine candidates.
Serological assays to assess immune response to a vaccine
Antigen-down serological assays on Simple Western can be used to assess antibody levels and characterize the immune response during vaccine development. Time course studies can be used to quantify durability of response. Using combinations of viral antigens for antibody capture provide robust measurements of antibody binding profiles and information about relative immunogenicity of viral antigens. Further, a western blotting-based serology test is often an important datapoint for confirming lateral flow, ELISA or other immunoassay serology techniques.
Characterize vaccine proteins and monitor vaccine component expression over time
Manufacture of vaccines requires rigorous analytical characterization of vaccine components to assess identity and stability. Enjoy the benefits that Simple Western assays offer over traditional approaches like ELISA and manual western blotting including speed, automation, reproducibility. Simple Westerns enable vaccine researchers to quantify vaccine proteins using a standard curve, identify protein fragments, and track protein expression over time. Learn how scientists from Merck Research Laboratories used Simple Western assays to quantitate specific components in vaccine candidates with high reproducibility.
Quantitate vaccine manufacturing process intermediate contamination
When manufacturing a vaccine, Simple Western can be used to determine the amount of residual BSA in samples collected throughout the vaccine manufacturing and purification process. In Loughney et al, 2014, ELISAs were not accurate enough for residual BSA quantitation. Traditional SDS PAGE could not be used due to the size of the vaccine proteins which were too close in molecular weight to BSA. In this publication, Simple Western assay was utilized to measure BSA in various process intermediates in their vaccine manufacturing process, enabling the design of a robust and scalable manufacturing process.